| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histone Deacetylases | 74 | 2024 | 210 | 12.680 |
Why?
|
| Histone Deacetylase Inhibitors | 33 | 2023 | 220 | 6.470 |
Why?
|
| Cardiomegaly | 35 | 2025 | 172 | 5.780 |
Why?
|
| Myocardium | 38 | 2025 | 939 | 4.990 |
Why?
|
| Myocytes, Cardiac | 40 | 2025 | 551 | 4.960 |
Why?
|
| Heart Failure | 35 | 2026 | 2314 | 4.760 |
Why?
|
| Fibroblasts | 27 | 2025 | 1032 | 2.960 |
Why?
|
| Fibrosis | 20 | 2024 | 547 | 2.900 |
Why?
|
| Ventricular Remodeling | 15 | 2025 | 275 | 2.800 |
Why?
|
| Heart | 18 | 2022 | 633 | 2.790 |
Why?
|
| Transcription Factors | 34 | 2024 | 1739 | 2.450 |
Why?
|
| Protein Kinase C | 18 | 2015 | 252 | 2.390 |
Why?
|
| Nuclear Proteins | 10 | 2024 | 748 | 1.910 |
Why?
|
| Myofibrils | 8 | 2023 | 49 | 1.900 |
Why?
|
| Signal Transduction | 54 | 2025 | 5221 | 1.850 |
Why?
|
| Epigenesis, Genetic | 13 | 2025 | 684 | 1.840 |
Why?
|
| Animals | 145 | 2026 | 38030 | 1.800 |
Why?
|
| Adipocytes | 5 | 2025 | 223 | 1.690 |
Why?
|
| Myofibroblasts | 5 | 2023 | 143 | 1.660 |
Why?
|
| Thermogenesis | 4 | 2025 | 45 | 1.630 |
Why?
|
| Hypertrophy, Right Ventricular | 4 | 2021 | 150 | 1.610 |
Why?
|
| Rats | 49 | 2022 | 5592 | 1.570 |
Why?
|
| Gene Expression Regulation | 33 | 2026 | 2603 | 1.390 |
Why?
|
| Extracellular Matrix | 6 | 2023 | 553 | 1.380 |
Why?
|
| Cells, Cultured | 37 | 2025 | 4146 | 1.380 |
Why?
|
| Chromatin | 10 | 2024 | 561 | 1.370 |
Why?
|
| Mice | 70 | 2026 | 18329 | 1.310 |
Why?
|
| Rats, Sprague-Dawley | 31 | 2021 | 2525 | 1.250 |
Why?
|
| Dual-Specificity Phosphatases | 3 | 2021 | 10 | 1.220 |
Why?
|
| Protein Processing, Post-Translational | 8 | 2023 | 477 | 1.160 |
Why?
|
| Hypertension, Pulmonary | 11 | 2021 | 1980 | 1.130 |
Why?
|
| Heart Ventricles | 13 | 2022 | 756 | 1.100 |
Why?
|
| Azepines | 4 | 2024 | 107 | 1.100 |
Why?
|
| Histones | 13 | 2020 | 668 | 1.100 |
Why?
|
| Angiotensin II | 5 | 2021 | 97 | 1.060 |
Why?
|
| Triazoles | 4 | 2024 | 184 | 1.030 |
Why?
|
| Adipose Tissue | 4 | 2025 | 651 | 0.990 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2024 | 137 | 0.980 |
Why?
|
| Heart-Assist Devices | 3 | 2025 | 567 | 0.960 |
Why?
|
| Gene Expression Regulation, Enzymologic | 7 | 2019 | 269 | 0.930 |
Why?
|
| Phosphorylation | 27 | 2023 | 1732 | 0.910 |
Why?
|
| Cell Cycle Proteins | 5 | 2024 | 628 | 0.890 |
Why?
|
| DNA-Binding Proteins | 32 | 2005 | 1497 | 0.880 |
Why?
|
| Hydroxamic Acids | 6 | 2018 | 94 | 0.880 |
Why?
|
| Lysine | 6 | 2022 | 302 | 0.870 |
Why?
|
| Vascular Remodeling | 3 | 2021 | 204 | 0.850 |
Why?
|
| Acetylation | 15 | 2020 | 252 | 0.840 |
Why?
|
| Muscle, Skeletal | 12 | 2023 | 1792 | 0.830 |
Why?
|
| Myocytes, Smooth Muscle | 5 | 2021 | 266 | 0.810 |
Why?
|
| Humans | 108 | 2026 | 144261 | 0.800 |
Why?
|
| Catecholamines | 1 | 2023 | 87 | 0.790 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2024 | 70 | 0.790 |
Why?
|
| Sarcomeres | 3 | 2022 | 98 | 0.780 |
Why?
|
| Disease Models, Animal | 24 | 2026 | 4556 | 0.780 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2024 | 364 | 0.770 |
Why?
|
| Heart Diseases | 4 | 2021 | 349 | 0.760 |
Why?
|
| Repressor Proteins | 15 | 2019 | 437 | 0.750 |
Why?
|
| Adipose Tissue, Brown | 2 | 2023 | 59 | 0.740 |
Why?
|
| Rejuvenation | 1 | 2022 | 18 | 0.740 |
Why?
|
| Myocardial Infarction | 4 | 2024 | 1208 | 0.730 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2022 | 43 | 0.710 |
Why?
|
| Cell Proliferation | 5 | 2021 | 2494 | 0.700 |
Why?
|
| Assisted Circulation | 1 | 2021 | 26 | 0.700 |
Why?
|
| Heart Murmurs | 1 | 2021 | 14 | 0.680 |
Why?
|
| MEF2 Transcription Factors | 20 | 2020 | 51 | 0.680 |
Why?
|
| Macrophages | 5 | 2024 | 1510 | 0.670 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2022 | 390 | 0.670 |
Why?
|
| Mice, Inbred C57BL | 22 | 2025 | 5988 | 0.670 |
Why?
|
| Animals, Newborn | 14 | 2017 | 901 | 0.660 |
Why?
|
| Cell Nucleus | 13 | 2015 | 618 | 0.660 |
Why?
|
| Arteries | 1 | 2022 | 258 | 0.650 |
Why?
|
| Obesity | 4 | 2025 | 3057 | 0.650 |
Why?
|
| Epigenomics | 3 | 2021 | 114 | 0.640 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2020 | 56 | 0.640 |
Why?
|
| Aortic Diseases | 1 | 2021 | 124 | 0.630 |
Why?
|
| Mice, Knockout | 13 | 2026 | 3119 | 0.630 |
Why?
|
| NF-kappa B | 11 | 2024 | 661 | 0.620 |
Why?
|
| Muscle Proteins | 6 | 2025 | 244 | 0.620 |
Why?
|
| Histone Deacetylase 6 | 6 | 2022 | 17 | 0.610 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2017 | 427 | 0.610 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 12 | 2006 | 167 | 0.600 |
Why?
|
| Calcineurin | 12 | 2008 | 105 | 0.560 |
Why?
|
| Pulmonary Artery | 4 | 2021 | 1134 | 0.560 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2019 | 95 | 0.560 |
Why?
|
| Cardiovascular Agents | 4 | 2025 | 163 | 0.560 |
Why?
|
| I-kappa B Proteins | 8 | 2000 | 74 | 0.550 |
Why?
|
| Myogenic Regulatory Factors | 18 | 2009 | 45 | 0.540 |
Why?
|
| T-Lymphocytes | 6 | 2022 | 1982 | 0.540 |
Why?
|
| Drug Discovery | 2 | 2016 | 154 | 0.530 |
Why?
|
| Oxidative Stress | 3 | 2019 | 1339 | 0.520 |
Why?
|
| Carrier Proteins | 8 | 2013 | 736 | 0.510 |
Why?
|
| Karyopherins | 2 | 2009 | 20 | 0.510 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2019 | 459 | 0.510 |
Why?
|
| Immunotherapy | 1 | 2022 | 652 | 0.510 |
Why?
|
| Models, Biological | 15 | 2022 | 1820 | 0.500 |
Why?
|
| Muscle, Smooth, Vascular | 5 | 2021 | 452 | 0.500 |
Why?
|
| High-Throughput Screening Assays | 2 | 2016 | 174 | 0.500 |
Why?
|
| Histone Acetyltransferases | 3 | 2014 | 62 | 0.500 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2017 | 173 | 0.490 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 4 | 2009 | 209 | 0.480 |
Why?
|
| Male | 55 | 2026 | 72035 | 0.470 |
Why?
|
| Blood Pressure | 6 | 2022 | 1759 | 0.470 |
Why?
|
| Fatty Liver | 1 | 2018 | 251 | 0.460 |
Why?
|
| Alkaline Phosphatase | 2 | 2017 | 143 | 0.460 |
Why?
|
| Protein Binding | 13 | 2019 | 2270 | 0.460 |
Why?
|
| Active Transport, Cell Nucleus | 10 | 2010 | 121 | 0.460 |
Why?
|
| Transforming Growth Factor beta | 6 | 2021 | 479 | 0.450 |
Why?
|
| Enzyme Inhibitors | 6 | 2016 | 824 | 0.450 |
Why?
|
| Carbazoles | 1 | 2015 | 56 | 0.440 |
Why?
|
| Microtubules | 1 | 2017 | 286 | 0.430 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2014 | 35 | 0.430 |
Why?
|
| Transcription, Genetic | 17 | 2014 | 1495 | 0.430 |
Why?
|
| Sumoylation | 1 | 2014 | 18 | 0.430 |
Why?
|
| Receptors, Endothelin | 1 | 2014 | 50 | 0.430 |
Why?
|
| SUMO-1 Protein | 1 | 2014 | 22 | 0.430 |
Why?
|
| Cardiotonic Agents | 2 | 2014 | 95 | 0.430 |
Why?
|
| MicroRNAs | 4 | 2021 | 700 | 0.420 |
Why?
|
| Pyrroles | 1 | 2015 | 217 | 0.400 |
Why?
|
| Muscular Atrophy | 1 | 2014 | 89 | 0.390 |
Why?
|
| YY1 Transcription Factor | 2 | 2015 | 23 | 0.390 |
Why?
|
| Induced Pluripotent Stem Cells | 5 | 2025 | 276 | 0.380 |
Why?
|
| Phenotype | 9 | 2025 | 3157 | 0.380 |
Why?
|
| Stroke Volume | 6 | 2025 | 648 | 0.380 |
Why?
|
| Calcium | 4 | 2023 | 1182 | 0.370 |
Why?
|
| Myocardial Contraction | 5 | 2023 | 298 | 0.370 |
Why?
|
| Transcriptome | 7 | 2025 | 1044 | 0.370 |
Why?
|
| Hydrogels | 4 | 2025 | 697 | 0.370 |
Why?
|
| Isoenzymes | 7 | 2017 | 299 | 0.360 |
Why?
|
| Enhancer Elements, Genetic | 5 | 2024 | 192 | 0.360 |
Why?
|
| Immunoblotting | 5 | 2014 | 300 | 0.350 |
Why?
|
| Troponin I | 2 | 2023 | 72 | 0.340 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2024 | 109 | 0.340 |
Why?
|
| Myosin Heavy Chains | 4 | 2010 | 182 | 0.330 |
Why?
|
| Cell Culture Techniques | 2 | 2025 | 375 | 0.320 |
Why?
|
| Membrane Glycoproteins | 2 | 2005 | 496 | 0.320 |
Why?
|
| Proteome | 2 | 2025 | 514 | 0.320 |
Why?
|
| Connectin | 2 | 2022 | 42 | 0.320 |
Why?
|
| Stem Cell Transplantation | 2 | 2021 | 191 | 0.320 |
Why?
|
| Nuclear Localization Signals | 1 | 2010 | 17 | 0.320 |
Why?
|
| Benzamides | 3 | 2019 | 224 | 0.310 |
Why?
|
| RNA Polymerase II | 3 | 2019 | 350 | 0.310 |
Why?
|
| COS Cells | 9 | 2010 | 181 | 0.310 |
Why?
|
| HEK293 Cells | 4 | 2019 | 744 | 0.310 |
Why?
|
| Proteomics | 4 | 2025 | 1191 | 0.310 |
Why?
|
| Cell Line | 17 | 2021 | 2879 | 0.310 |
Why?
|
| Cardiomyopathy, Dilated | 4 | 2025 | 359 | 0.290 |
Why?
|
| Ventricular Function, Left | 3 | 2025 | 538 | 0.290 |
Why?
|
| Membrane Proteins | 1 | 2015 | 1165 | 0.290 |
Why?
|
| Protein Isoforms | 4 | 2013 | 402 | 0.280 |
Why?
|
| RNA-Binding Proteins | 3 | 2021 | 462 | 0.280 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2022 | 138 | 0.280 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2010 | 593 | 0.280 |
Why?
|
| Aortic Valve | 3 | 2022 | 360 | 0.270 |
Why?
|
| Tissue Engineering | 2 | 2025 | 440 | 0.270 |
Why?
|
| Cell Differentiation | 9 | 2025 | 2048 | 0.270 |
Why?
|
| Inflammation Mediators | 3 | 2021 | 508 | 0.270 |
Why?
|
| Cardiomyopathies | 2 | 2023 | 337 | 0.260 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 2516 | 0.260 |
Why?
|
| Amino Acid Sequence | 12 | 2016 | 2154 | 0.260 |
Why?
|
| T-Box Domain Proteins | 2 | 2026 | 106 | 0.250 |
Why?
|
| Pyridines | 3 | 2022 | 605 | 0.250 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2011 | 968 | 0.250 |
Why?
|
| TRPC Cation Channels | 1 | 2006 | 14 | 0.250 |
Why?
|
| Ankyrins | 2 | 2005 | 12 | 0.240 |
Why?
|
| GATA4 Transcription Factor | 4 | 2020 | 19 | 0.230 |
Why?
|
| Stress, Physiological | 2 | 2006 | 453 | 0.220 |
Why?
|
| Gene Regulatory Networks | 2 | 2026 | 318 | 0.220 |
Why?
|
| Acetyltransferases | 2 | 2002 | 21 | 0.220 |
Why?
|
| Small Molecule Libraries | 2 | 2016 | 110 | 0.220 |
Why?
|
| RNA, Messenger | 9 | 2022 | 2829 | 0.220 |
Why?
|
| Female | 28 | 2025 | 77976 | 0.220 |
Why?
|
| Protein Kinases | 2 | 2007 | 315 | 0.220 |
Why?
|
| Citalopram | 1 | 2025 | 32 | 0.220 |
Why?
|
| Cortical Bone | 2 | 2021 | 15 | 0.220 |
Why?
|
| Acylation | 2 | 2022 | 30 | 0.220 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2025 | 40 | 0.220 |
Why?
|
| Cardiac Output, Low | 1 | 2005 | 54 | 0.220 |
Why?
|
| Proteins | 4 | 2021 | 1021 | 0.220 |
Why?
|
| Calcium Signaling | 4 | 2015 | 251 | 0.220 |
Why?
|
| Nanotubes, Carbon | 1 | 2025 | 48 | 0.220 |
Why?
|
| Deuterium | 1 | 2025 | 100 | 0.220 |
Why?
|
| 3T3-L1 Cells | 2 | 2022 | 36 | 0.210 |
Why?
|
| MAP Kinase Signaling System | 3 | 2021 | 309 | 0.210 |
Why?
|
| Cyclophilins | 1 | 2024 | 40 | 0.210 |
Why?
|
| Aging | 2 | 2015 | 1964 | 0.210 |
Why?
|
| Estrogens | 2 | 2020 | 380 | 0.210 |
Why?
|
| Hypertension | 3 | 2011 | 1254 | 0.210 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2021 | 145 | 0.210 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2021 | 905 | 0.210 |
Why?
|
| Sequence Analysis, RNA | 3 | 2021 | 442 | 0.200 |
Why?
|
| Uncoupling Protein 1 | 1 | 2023 | 17 | 0.200 |
Why?
|
| Mice, Transgenic | 12 | 2023 | 2182 | 0.200 |
Why?
|
| Calcinosis | 2 | 2017 | 233 | 0.200 |
Why?
|
| Autophagy | 2 | 2017 | 285 | 0.200 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2022 | 177 | 0.200 |
Why?
|
| Transcriptional Activation | 7 | 2013 | 382 | 0.200 |
Why?
|
| Adaptation, Physiological | 4 | 2017 | 569 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2013 | 981 | 0.190 |
Why?
|
| Diet, High-Fat | 3 | 2022 | 261 | 0.190 |
Why?
|
| Hypoxia | 5 | 2013 | 1199 | 0.190 |
Why?
|
| Genetic Therapy | 1 | 2005 | 313 | 0.190 |
Why?
|
| Valproic Acid | 2 | 2013 | 47 | 0.190 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2017 | 360 | 0.190 |
Why?
|
| Enzyme Activation | 6 | 2022 | 765 | 0.190 |
Why?
|
| Cell Communication | 1 | 2024 | 324 | 0.190 |
Why?
|
| Endocardium | 1 | 2022 | 31 | 0.180 |
Why?
|
| Molecular Sequence Data | 13 | 2011 | 2929 | 0.180 |
Why?
|
| Metalloproteases | 1 | 2022 | 42 | 0.180 |
Why?
|
| Acute Kidney Injury | 2 | 2022 | 862 | 0.180 |
Why?
|
| NFATC Transcription Factors | 6 | 2006 | 93 | 0.180 |
Why?
|
| Immunohistochemistry | 4 | 2021 | 1715 | 0.180 |
Why?
|
| Cell Physiological Phenomena | 1 | 2002 | 19 | 0.180 |
Why?
|
| Thiophenes | 1 | 2022 | 128 | 0.180 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2023 | 91 | 0.180 |
Why?
|
| Matrix Metalloproteinases, Secreted | 1 | 2021 | 12 | 0.180 |
Why?
|
| ADAMTS4 Protein | 1 | 2021 | 16 | 0.180 |
Why?
|
| Long Term Adverse Effects | 1 | 2021 | 13 | 0.180 |
Why?
|
| Menopause | 1 | 2025 | 319 | 0.180 |
Why?
|
| Macrophage Activation | 2 | 2021 | 193 | 0.180 |
Why?
|
| Inflammation | 4 | 2017 | 2877 | 0.180 |
Why?
|
| Thiazepines | 1 | 2021 | 6 | 0.180 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2001 | 71 | 0.180 |
Why?
|
| Hemodynamics | 2 | 2018 | 1119 | 0.180 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2022 | 54 | 0.180 |
Why?
|
| Polymerase Chain Reaction | 3 | 2013 | 1054 | 0.170 |
Why?
|
| Homeodomain Proteins | 2 | 2024 | 523 | 0.170 |
Why?
|
| Cellular Senescence | 1 | 2023 | 226 | 0.170 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2021 | 72 | 0.170 |
Why?
|
| Paracrine Communication | 1 | 2021 | 67 | 0.170 |
Why?
|
| Structure-Activity Relationship | 6 | 2011 | 567 | 0.170 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2002 | 418 | 0.170 |
Why?
|
| Biocompatible Materials | 1 | 2025 | 435 | 0.170 |
Why?
|
| Adenylate Kinase | 3 | 2013 | 27 | 0.170 |
Why?
|
| Heart Rate | 1 | 2025 | 849 | 0.170 |
Why?
|
| Naphthyridines | 2 | 2010 | 20 | 0.160 |
Why?
|
| Vasoconstrictor Agents | 1 | 2021 | 144 | 0.160 |
Why?
|
| Serine | 5 | 2006 | 145 | 0.160 |
Why?
|
| Exosomes | 1 | 2021 | 104 | 0.160 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2011 | 194 | 0.160 |
Why?
|
| Microscopy, Fluorescence | 3 | 2009 | 416 | 0.160 |
Why?
|
| RNA Interference | 2 | 2013 | 476 | 0.160 |
Why?
|
| Histone Deacetylase 2 | 3 | 2013 | 10 | 0.160 |
Why?
|
| Leptin | 1 | 2022 | 244 | 0.160 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2020 | 64 | 0.160 |
Why?
|
| Catalytic Domain | 3 | 2015 | 232 | 0.150 |
Why?
|
| Immunoglobulins | 1 | 2000 | 160 | 0.150 |
Why?
|
| Succinic Acid | 1 | 2019 | 42 | 0.150 |
Why?
|
| Aminopyridines | 2 | 2010 | 127 | 0.150 |
Why?
|
| Protein Transport | 3 | 2009 | 441 | 0.150 |
Why?
|
| Atrial Fibrillation | 1 | 2026 | 548 | 0.150 |
Why?
|
| Diastole | 1 | 2020 | 141 | 0.150 |
Why?
|
| Histone Deacetylase 1 | 2 | 2017 | 23 | 0.150 |
Why?
|
| Serum | 1 | 2019 | 56 | 0.150 |
Why?
|
| Ventricular Function | 1 | 2019 | 57 | 0.150 |
Why?
|
| Biomimetics | 1 | 2019 | 40 | 0.150 |
Why?
|
| Oxadiazoles | 1 | 2019 | 37 | 0.150 |
Why?
|
| Phosphodiesterase 3 Inhibitors | 1 | 2019 | 14 | 0.150 |
Why?
|
| Cardio-Renal Syndrome | 1 | 2019 | 17 | 0.140 |
Why?
|
| Machine Learning | 1 | 2025 | 585 | 0.140 |
Why?
|
| Heart Failure, Diastolic | 1 | 2019 | 24 | 0.140 |
Why?
|
| Receptor Cross-Talk | 1 | 2018 | 21 | 0.140 |
Why?
|
| Reperfusion Injury | 1 | 2022 | 300 | 0.140 |
Why?
|
| Energy Metabolism | 3 | 2022 | 935 | 0.140 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 297 | 0.140 |
Why?
|
| Pyrimidines | 2 | 2013 | 532 | 0.140 |
Why?
|
| Cardiovascular Diseases | 4 | 2025 | 2134 | 0.140 |
Why?
|
| Biopsy | 1 | 2022 | 1075 | 0.140 |
Why?
|
| Wound Healing | 1 | 2021 | 351 | 0.140 |
Why?
|
| Mitochondria, Heart | 1 | 2019 | 102 | 0.140 |
Why?
|
| Histone Code | 1 | 2018 | 38 | 0.140 |
Why?
|
| 3' Untranslated Regions | 2 | 2016 | 152 | 0.140 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 266 | 0.140 |
Why?
|
| Adipose Tissue, White | 1 | 2018 | 43 | 0.140 |
Why?
|
| Cell Adhesion Molecules | 1 | 2019 | 177 | 0.140 |
Why?
|
| Metal Nanoparticles | 1 | 2019 | 85 | 0.140 |
Why?
|
| Gold | 1 | 2019 | 115 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2017 | 1217 | 0.140 |
Why?
|
| RNA, Small Interfering | 3 | 2011 | 634 | 0.140 |
Why?
|
| Myocardial Ischemia | 1 | 2019 | 284 | 0.130 |
Why?
|
| Amides | 2 | 2009 | 101 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2017 | 7 | 0.130 |
Why?
|
| Case-Control Studies | 3 | 2021 | 3592 | 0.130 |
Why?
|
| 14-3-3 Proteins | 3 | 2010 | 15 | 0.130 |
Why?
|
| Mitochondrial Proteins | 1 | 2019 | 261 | 0.130 |
Why?
|
| Adenoviridae | 2 | 2011 | 199 | 0.130 |
Why?
|
| Myosins | 1 | 2018 | 136 | 0.130 |
Why?
|
| Feedback, Physiological | 1 | 2017 | 83 | 0.130 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2019 | 146 | 0.130 |
Why?
|
| Calcineurin Inhibitors | 3 | 2004 | 69 | 0.130 |
Why?
|
| Middle Aged | 11 | 2025 | 35762 | 0.130 |
Why?
|
| Protein Domains | 1 | 2019 | 313 | 0.130 |
Why?
|
| Metabolic Syndrome | 1 | 2021 | 352 | 0.130 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2017 | 153 | 0.130 |
Why?
|
| Down-Regulation | 2 | 2016 | 627 | 0.130 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2017 | 16 | 0.130 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 4 | 2008 | 195 | 0.130 |
Why?
|
| Synovial Membrane | 2 | 2016 | 124 | 0.130 |
Why?
|
| Human T-lymphotropic virus 1 | 2 | 1996 | 32 | 0.130 |
Why?
|
| Lymphocyte Activation | 2 | 2000 | 1126 | 0.130 |
Why?
|
| Stem Cells | 1 | 2021 | 625 | 0.130 |
Why?
|
| Kinetics | 5 | 2025 | 1627 | 0.120 |
Why?
|
| Tissue Scaffolds | 1 | 2019 | 219 | 0.120 |
Why?
|
| Gap Junctions | 1 | 2017 | 67 | 0.120 |
Why?
|
| Tubulin | 2 | 2015 | 147 | 0.120 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2016 | 54 | 0.120 |
Why?
|
| CapZ Actin Capping Protein | 1 | 2016 | 2 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 336 | 0.120 |
Why?
|
| Kidney | 2 | 2022 | 1495 | 0.120 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2016 | 1168 | 0.120 |
Why?
|
| Synoviocytes | 1 | 2016 | 18 | 0.120 |
Why?
|
| Gene Products, tat | 1 | 1996 | 22 | 0.120 |
Why?
|
| Transcription Initiation Site | 1 | 2016 | 43 | 0.120 |
Why?
|
| Transcription Elongation, Genetic | 1 | 2016 | 24 | 0.120 |
Why?
|
| RNA, Long Noncoding | 1 | 2018 | 177 | 0.120 |
Why?
|
| Cell Movement | 4 | 2015 | 965 | 0.120 |
Why?
|
| Serum Response Factor | 1 | 2016 | 33 | 0.120 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 621 | 0.120 |
Why?
|
| Molecular Imaging | 1 | 2016 | 55 | 0.120 |
Why?
|
| Binding Sites | 6 | 2008 | 1327 | 0.120 |
Why?
|
| Cellular Reprogramming Techniques | 1 | 2015 | 11 | 0.120 |
Why?
|
| Ischemia | 1 | 2019 | 421 | 0.110 |
Why?
|
| Hypertrophy | 3 | 2023 | 127 | 0.110 |
Why?
|
| MyoD Protein | 4 | 2002 | 31 | 0.110 |
Why?
|
| Interleukins | 1 | 2017 | 248 | 0.110 |
Why?
|
| Positron-Emission Tomography | 1 | 2017 | 323 | 0.110 |
Why?
|
| Cell Cycle | 2 | 2019 | 596 | 0.110 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 3403 | 0.110 |
Why?
|
| Osteogenesis | 1 | 2017 | 206 | 0.110 |
Why?
|
| rho-Associated Kinases | 1 | 2015 | 83 | 0.110 |
Why?
|
| Ventricular Function, Right | 1 | 2017 | 297 | 0.110 |
Why?
|
| Chagas Cardiomyopathy | 1 | 2015 | 27 | 0.110 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2016 | 164 | 0.110 |
Why?
|
| Cellular Reprogramming | 1 | 2015 | 103 | 0.110 |
Why?
|
| Endopeptidases | 1 | 2014 | 82 | 0.110 |
Why?
|
| Biocatalysis | 1 | 2014 | 69 | 0.110 |
Why?
|
| Transcription Factor CHOP | 1 | 2014 | 32 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 5 | 2016 | 1255 | 0.110 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2014 | 29 | 0.100 |
Why?
|
| Superoxide Dismutase | 1 | 2016 | 301 | 0.100 |
Why?
|
| Systole | 1 | 2014 | 178 | 0.100 |
Why?
|
| Aortic Valve Stenosis | 1 | 2017 | 248 | 0.100 |
Why?
|
| Transfection | 8 | 2015 | 938 | 0.100 |
Why?
|
| Physical Exertion | 1 | 2014 | 207 | 0.100 |
Why?
|
| Estrogen Receptor beta | 1 | 2013 | 43 | 0.100 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2015 | 212 | 0.100 |
Why?
|
| Interleukin-1beta | 3 | 2024 | 395 | 0.100 |
Why?
|
| Phosphoproteins | 3 | 2001 | 343 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2013 | 175 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 436 | 0.090 |
Why?
|
| Recombinant Proteins | 7 | 2017 | 1367 | 0.090 |
Why?
|
| Endothelin-1 | 2 | 2011 | 184 | 0.090 |
Why?
|
| Membrane Transport Proteins | 1 | 2013 | 154 | 0.090 |
Why?
|
| Endoplasmic Reticulum | 1 | 2014 | 266 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2014 | 321 | 0.090 |
Why?
|
| Retroviridae Proteins, Oncogenic | 3 | 1997 | 10 | 0.090 |
Why?
|
| Vascular Diseases | 1 | 2014 | 250 | 0.090 |
Why?
|
| Adrenergic beta-1 Receptor Agonists | 1 | 2011 | 3 | 0.090 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 458 | 0.090 |
Why?
|
| Azoles | 1 | 2011 | 4 | 0.080 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 2011 | 45 | 0.080 |
Why?
|
| Cell Size | 2 | 2016 | 92 | 0.080 |
Why?
|
| Materials Testing | 2 | 2025 | 354 | 0.080 |
Why?
|
| Cats | 2 | 2022 | 228 | 0.080 |
Why?
|
| 2,2'-Dipyridyl | 1 | 2010 | 7 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2022 | 2026 | 0.080 |
Why?
|
| Norepinephrine | 1 | 2011 | 196 | 0.080 |
Why?
|
| Rats, Inbred Dahl | 3 | 2020 | 9 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 125 | 0.080 |
Why?
|
| Consensus Sequence | 1 | 2010 | 74 | 0.080 |
Why?
|
| Indoles | 1 | 2014 | 501 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2010 | 330 | 0.080 |
Why?
|
| Molecular Structure | 2 | 2011 | 498 | 0.080 |
Why?
|
| Estradiol | 1 | 2013 | 533 | 0.080 |
Why?
|
| Insulin Resistance | 1 | 2018 | 1232 | 0.080 |
Why?
|
| Atrial Natriuretic Factor | 3 | 2004 | 56 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2013 | 1172 | 0.080 |
Why?
|
| Models, Animal | 1 | 2011 | 392 | 0.080 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2005 | 578 | 0.080 |
Why?
|
| Regional Blood Flow | 1 | 2012 | 512 | 0.080 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 356 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 151 | 0.080 |
Why?
|
| Protein Interaction Mapping | 1 | 2010 | 103 | 0.080 |
Why?
|
| Mutation | 6 | 2014 | 4085 | 0.070 |
Why?
|
| Embryo, Mammalian | 3 | 2020 | 232 | 0.070 |
Why?
|
| Cytokines | 2 | 2014 | 2061 | 0.070 |
Why?
|
| Heart Defects, Congenital | 1 | 2017 | 913 | 0.070 |
Why?
|
| Cattle | 4 | 2013 | 999 | 0.070 |
Why?
|
| Cell Survival | 3 | 2015 | 1098 | 0.070 |
Why?
|
| Precipitin Tests | 3 | 2004 | 93 | 0.070 |
Why?
|
| Phenylephrine | 2 | 2021 | 75 | 0.070 |
Why?
|
| NF-KappaB Inhibitor alpha | 5 | 2000 | 49 | 0.070 |
Why?
|
| Immunologic Factors | 1 | 2011 | 255 | 0.070 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2020 | 214 | 0.070 |
Why?
|
| Aniline Compounds | 1 | 2009 | 119 | 0.070 |
Why?
|
| Aged | 5 | 2025 | 25850 | 0.070 |
Why?
|
| Drug Design | 1 | 2009 | 173 | 0.070 |
Why?
|
| Organ Culture Techniques | 2 | 2019 | 154 | 0.070 |
Why?
|
| Cyclosporine | 2 | 1999 | 265 | 0.070 |
Why?
|
| Up-Regulation | 2 | 2025 | 851 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 3 | 1996 | 623 | 0.070 |
Why?
|
| Swine | 2 | 2021 | 831 | 0.070 |
Why?
|
| Piperazines | 1 | 2010 | 380 | 0.070 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2007 | 28 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2014 | 653 | 0.070 |
Why?
|
| Adult | 8 | 2019 | 40262 | 0.070 |
Why?
|
| Muscle Fatigue | 1 | 2008 | 97 | 0.060 |
Why?
|
| Substrate Specificity | 2 | 2006 | 388 | 0.060 |
Why?
|
| Diet | 1 | 2014 | 1271 | 0.060 |
Why?
|
| Apoptosis | 4 | 2021 | 2430 | 0.060 |
Why?
|
| Neovascularization, Physiologic | 1 | 2008 | 194 | 0.060 |
Why?
|
| Rats, Inbred WF | 1 | 2006 | 8 | 0.060 |
Why?
|
| Thiadiazoles | 1 | 2006 | 27 | 0.060 |
Why?
|
| Rats, Inbred SHR | 1 | 2006 | 37 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2000 | 339 | 0.060 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2006 | 20 | 0.060 |
Why?
|
| Biological Transport | 2 | 2013 | 412 | 0.060 |
Why?
|
| Cocaine-Related Disorders | 1 | 2007 | 130 | 0.060 |
Why?
|
| Anilides | 1 | 2006 | 84 | 0.060 |
Why?
|
| Transcription Factor RelA | 2 | 2024 | 85 | 0.060 |
Why?
|
| Models, Genetic | 3 | 2004 | 535 | 0.060 |
Why?
|
| SOX9 Transcription Factor | 1 | 2026 | 28 | 0.060 |
Why?
|
| Adenosine Diphosphate | 1 | 2006 | 84 | 0.060 |
Why?
|
| Neurons | 1 | 2015 | 1640 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 8243 | 0.060 |
Why?
|
| Gene Deletion | 3 | 2017 | 387 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 2 | 2008 | 862 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2010 | 425 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 379 | 0.060 |
Why?
|
| Base Sequence | 6 | 2006 | 2187 | 0.060 |
Why?
|
| Nuclear Envelope | 1 | 2006 | 46 | 0.060 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2026 | 78 | 0.060 |
Why?
|
| Cyclohexenes | 1 | 2025 | 5 | 0.060 |
Why?
|
| Vinyl Compounds | 1 | 2025 | 5 | 0.060 |
Why?
|
| Models, Anatomic | 1 | 2006 | 84 | 0.060 |
Why?
|
| Pneumonia | 1 | 2011 | 630 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2007 | 377 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2008 | 557 | 0.060 |
Why?
|
| Heart Atria | 1 | 2026 | 144 | 0.060 |
Why?
|
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2025 | 36 | 0.050 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2024 | 19 | 0.050 |
Why?
|
| Fluoresceins | 1 | 2004 | 48 | 0.050 |
Why?
|
| Injections | 1 | 2025 | 196 | 0.050 |
Why?
|
| Research Design | 2 | 2022 | 1129 | 0.050 |
Why?
|
| Adhesins, Bacterial | 1 | 2004 | 46 | 0.050 |
Why?
|
| Potassium Channels | 1 | 2025 | 145 | 0.050 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2015 | 139 | 0.050 |
Why?
|
| Administration, Oral | 3 | 2011 | 847 | 0.050 |
Why?
|
| Particle Size | 1 | 2025 | 406 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2025 | 250 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2015 | 341 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2006 | 498 | 0.050 |
Why?
|
| Metabolomics | 2 | 2019 | 726 | 0.050 |
Why?
|
| Jurkat Cells | 2 | 2000 | 114 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2004 | 405 | 0.050 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2023 | 49 | 0.050 |
Why?
|
| Time Factors | 1 | 2014 | 7155 | 0.050 |
Why?
|
| Tyrosine | 1 | 2023 | 221 | 0.050 |
Why?
|
| Methylation | 2 | 2019 | 242 | 0.050 |
Why?
|
| Cell Division | 2 | 2002 | 766 | 0.050 |
Why?
|
| Fluorescent Dyes | 1 | 2004 | 329 | 0.050 |
Why?
|
| Action Potentials | 2 | 2017 | 506 | 0.050 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2002 | 25 | 0.050 |
Why?
|
| Carbamates | 1 | 2023 | 52 | 0.050 |
Why?
|
| Sex Factors | 2 | 2022 | 2096 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2023 | 433 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 850 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2022 | 66 | 0.040 |
Why?
|
| Gene Expression | 4 | 2016 | 1487 | 0.040 |
Why?
|
| Massachusetts | 1 | 2022 | 177 | 0.040 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2001 | 2 | 0.040 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2001 | 13 | 0.040 |
Why?
|
| Temperature | 1 | 2025 | 678 | 0.040 |
Why?
|
| RNA, Small Nucleolar | 1 | 2021 | 8 | 0.040 |
Why?
|
| Sex Characteristics | 2 | 2019 | 789 | 0.040 |
Why?
|
| Rats, Transgenic | 1 | 2021 | 18 | 0.040 |
Why?
|
| Rats, Inbred BN | 1 | 2021 | 55 | 0.040 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2002 | 132 | 0.040 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2001 | 26 | 0.040 |
Why?
|
| Swine, Miniature | 1 | 2021 | 89 | 0.040 |
Why?
|
| Embryonic and Fetal Development | 1 | 2001 | 93 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2015 | 1187 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2001 | 193 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2004 | 668 | 0.040 |
Why?
|
| Muscle Development | 1 | 2001 | 115 | 0.040 |
Why?
|
| American Heart Association | 1 | 2022 | 348 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2025 | 886 | 0.040 |
Why?
|
| Cytoplasm | 3 | 2015 | 269 | 0.040 |
Why?
|
| Culture Media | 1 | 2021 | 160 | 0.040 |
Why?
|
| DNA Primers | 3 | 1996 | 511 | 0.040 |
Why?
|
| Muscle Cells | 2 | 2010 | 42 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2006 | 876 | 0.040 |
Why?
|
| Cell Death | 1 | 2002 | 383 | 0.040 |
Why?
|
| Peptides | 1 | 2006 | 995 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2025 | 2025 | 0.040 |
Why?
|
| Genes, ras | 1 | 2000 | 96 | 0.040 |
Why?
|
| Genetic Engineering | 1 | 2000 | 93 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2000 | 190 | 0.040 |
Why?
|
| Serotonin | 2 | 2016 | 293 | 0.040 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2019 | 8 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2007 | 1147 | 0.040 |
Why?
|
| Lung | 3 | 2020 | 4108 | 0.040 |
Why?
|
| Pharmacogenomic Testing | 1 | 2019 | 62 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2019 | 246 | 0.040 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 1999 | 121 | 0.030 |
Why?
|
| Pregnancy | 2 | 2022 | 7180 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2019 | 208 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2008 | 396 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2022 | 758 | 0.030 |
Why?
|
| RNA | 1 | 2004 | 939 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2021 | 450 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2019 | 221 | 0.030 |
Why?
|
| Body Weight | 1 | 2022 | 976 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 1519 | 0.030 |
Why?
|
| Autoradiography | 1 | 2017 | 64 | 0.030 |
Why?
|
| Fluorine Radioisotopes | 1 | 2017 | 13 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2000 | 555 | 0.030 |
Why?
|
| Papio | 1 | 2017 | 85 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2017 | 75 | 0.030 |
Why?
|
| Enzyme Repression | 1 | 2016 | 6 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 3 | 2000 | 5 | 0.030 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2016 | 23 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2019 | 424 | 0.030 |
Why?
|
| Antihypertensive Agents | 2 | 2010 | 509 | 0.030 |
Why?
|
| STAT1 Transcription Factor | 1 | 2016 | 68 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2019 | 612 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2017 | 194 | 0.030 |
Why?
|
| Multienzyme Complexes | 1 | 1996 | 67 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 1996 | 73 | 0.030 |
Why?
|
| Interferon-beta | 1 | 2016 | 92 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2004 | 674 | 0.030 |
Why?
|
| Echocardiography | 1 | 2019 | 647 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2020 | 681 | 0.030 |
Why?
|
| Collagen Type III | 1 | 2015 | 18 | 0.030 |
Why?
|
| Metabolome | 1 | 2019 | 384 | 0.030 |
Why?
|
| Lymphocytes | 1 | 1997 | 382 | 0.030 |
Why?
|
| Models, Molecular | 2 | 2010 | 1618 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 1996 | 159 | 0.030 |
Why?
|
| Cardiomegaly, Exercise-Induced | 1 | 2014 | 3 | 0.030 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2014 | 17 | 0.030 |
Why?
|
| Clathrin | 1 | 1995 | 26 | 0.030 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2014 | 21 | 0.030 |
Why?
|
| Blood Sedimentation | 1 | 2014 | 37 | 0.030 |
Why?
|
| Soybean Proteins | 1 | 2014 | 14 | 0.030 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2014 | 32 | 0.030 |
Why?
|
| Caseins | 1 | 2014 | 20 | 0.030 |
Why?
|
| Trypanosoma cruzi | 1 | 2015 | 39 | 0.030 |
Why?
|
| Viral Proteins | 1 | 1997 | 355 | 0.030 |
Why?
|
| Muscle Fibers, Slow-Twitch | 2 | 2008 | 23 | 0.030 |
Why?
|
| Ketocholesterols | 1 | 2014 | 8 | 0.030 |
Why?
|
| alpha-Crystallin B Chain | 1 | 2014 | 24 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2015 | 156 | 0.030 |
Why?
|
| Ezetimibe | 1 | 2014 | 24 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 135 | 0.030 |
Why?
|
| Azetidines | 1 | 2014 | 44 | 0.030 |
Why?
|
| Simvastatin | 1 | 2014 | 59 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2014 | 415 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 173 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2015 | 205 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2014 | 93 | 0.030 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 2013 | 17 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 1782 | 0.030 |
Why?
|
| Actins | 1 | 2016 | 422 | 0.030 |
Why?
|
| Isoquinolines | 1 | 2013 | 44 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 66 | 0.030 |
Why?
|
| Blood-Retinal Barrier | 1 | 2013 | 12 | 0.020 |
Why?
|
| Protein Kinase C-delta | 1 | 2013 | 46 | 0.020 |
Why?
|
| Calmodulin | 2 | 2006 | 70 | 0.020 |
Why?
|
| Receptor, Notch1 | 1 | 2013 | 64 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2013 | 115 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2013 | 112 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2014 | 190 | 0.020 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2013 | 40 | 0.020 |
Why?
|
| Liver | 1 | 2022 | 1884 | 0.020 |
Why?
|
| Mitochondria | 1 | 2020 | 983 | 0.020 |
Why?
|
| Familial Primary Pulmonary Hypertension | 1 | 2013 | 197 | 0.020 |
Why?
|
| Retroviridae | 1 | 1993 | 101 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 202 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 416 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2013 | 451 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2012 | 90 | 0.020 |
Why?
|
| Sequence Alignment | 2 | 2004 | 366 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 1253 | 0.020 |
Why?
|
| Oncogene Proteins v-rel | 3 | 1997 | 3 | 0.020 |
Why?
|
| Genes, Reporter | 2 | 2004 | 275 | 0.020 |
Why?
|
| Connective Tissue | 1 | 2011 | 39 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-rel | 3 | 1996 | 7 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 1995 | 627 | 0.020 |
Why?
|
| Chick Embryo | 3 | 1997 | 132 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2014 | 1044 | 0.020 |
Why?
|
| Cell Line, Transformed | 2 | 2002 | 140 | 0.020 |
Why?
|
| Aorta, Thoracic | 2 | 2007 | 286 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 1995 | 592 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2011 | 91 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 431 | 0.020 |
Why?
|
| DNA, Viral | 1 | 1993 | 358 | 0.020 |
Why?
|
| Biological Availability | 1 | 2011 | 142 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 370 | 0.020 |
Why?
|
| Retina | 1 | 2013 | 323 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2014 | 404 | 0.020 |
Why?
|
| MADS Domain Proteins | 1 | 2009 | 4 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2011 | 454 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2025 | 11643 | 0.020 |
Why?
|
| Lipids | 1 | 2014 | 700 | 0.020 |
Why?
|
| Colorado | 1 | 2019 | 4562 | 0.020 |
Why?
|
| Monocytes | 1 | 2011 | 538 | 0.020 |
Why?
|
| Neoplasms | 1 | 2004 | 2870 | 0.020 |
Why?
|
| Phospholipase C gamma | 1 | 2008 | 28 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2008 | 27 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 2359 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2008 | 116 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2008 | 85 | 0.020 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2007 | 58 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2008 | 172 | 0.020 |
Why?
|
| Brain | 1 | 1999 | 2930 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 2917 | 0.020 |
Why?
|
| Nucleus Accumbens | 1 | 2007 | 132 | 0.020 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2006 | 28 | 0.010 |
Why?
|
| Cocaine | 1 | 2007 | 160 | 0.010 |
Why?
|
| Chickens | 1 | 2006 | 191 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2006 | 276 | 0.010 |
Why?
|
| Reward | 1 | 2007 | 245 | 0.010 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2006 | 134 | 0.010 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2004 | 13 | 0.010 |
Why?
|
| Calcium Channels | 1 | 2006 | 154 | 0.010 |
Why?
|
| DNA | 2 | 2003 | 1460 | 0.010 |
Why?
|
| Receptors, Steroid | 1 | 2004 | 45 | 0.010 |
Why?
|
| Rabbits | 1 | 2006 | 648 | 0.010 |
Why?
|
| United States | 1 | 2022 | 15876 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2004 | 311 | 0.010 |
Why?
|
| Tritium | 1 | 2003 | 68 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2003 | 44 | 0.010 |
Why?
|
| Ventricular Myosins | 1 | 2003 | 37 | 0.010 |
Why?
|
| Infant | 1 | 2017 | 10022 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 1 | 1 | 2002 | 3 | 0.010 |
Why?
|
| Phosphotransferases | 1 | 2002 | 27 | 0.010 |
Why?
|
| Leucine | 1 | 2003 | 116 | 0.010 |
Why?
|
| Glycogen Synthase Kinases | 1 | 2002 | 3 | 0.010 |
Why?
|
| Emotions | 1 | 2007 | 577 | 0.010 |
Why?
|
| Methyltransferases | 1 | 2002 | 74 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 758 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2008 | 869 | 0.010 |
Why?
|
| Isoproterenol | 1 | 2002 | 96 | 0.010 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2002 | 81 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2007 | 1812 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2002 | 509 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2001 | 59 | 0.010 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2002 | 141 | 0.010 |
Why?
|
| Thyroid Hormones | 1 | 2000 | 66 | 0.010 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2001 | 62 | 0.010 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2000 | 17 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2001 | 224 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2001 | 224 | 0.010 |
Why?
|
| Luciferases | 1 | 2000 | 152 | 0.010 |
Why?
|
| Exons | 1 | 2000 | 358 | 0.010 |
Why?
|
| Expressed Sequence Tags | 1 | 1999 | 43 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2000 | 312 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 1999 | 53 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 13990 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2000 | 276 | 0.010 |
Why?
|
| Ligation | 1 | 1999 | 92 | 0.010 |
Why?
|
| Aorta, Abdominal | 1 | 1999 | 52 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1999 | 319 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1999 | 327 | 0.010 |
Why?
|
| Testis | 1 | 1999 | 163 | 0.010 |
Why?
|
| Fetus | 1 | 2003 | 803 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1999 | 539 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2000 | 682 | 0.010 |
Why?
|
| Motor Neurons | 1 | 2000 | 234 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 22281 | 0.010 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 1997 | 47 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1999 | 346 | 0.010 |
Why?
|
| Child | 1 | 2017 | 22537 | 0.010 |
Why?
|
| Proto-Oncogenes | 1 | 1996 | 29 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1996 | 80 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1996 | 141 | 0.010 |
Why?
|
| src Homology Domains | 1 | 1996 | 35 | 0.010 |
Why?
|
| Aorta | 1 | 1999 | 429 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 1999 | 824 | 0.010 |
Why?
|
| Gene Products, tax | 1 | 1995 | 15 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1996 | 919 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1995 | 156 | 0.010 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 1995 | 44 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1995 | 381 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2000 | 676 | 0.010 |
Why?
|
| Transcription Factor RelB | 1 | 1993 | 3 | 0.010 |
Why?
|
| Cell Transformation, Viral | 1 | 1993 | 23 | 0.010 |
Why?
|
| Databases, Factual | 1 | 1999 | 1484 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1996 | 698 | 0.010 |
Why?
|
| Antibodies | 1 | 1995 | 401 | 0.010 |
Why?
|
| Birds | 1 | 1993 | 92 | 0.010 |
Why?
|
| Spleen | 1 | 1993 | 508 | 0.010 |
Why?
|
| HIV-1 | 1 | 1995 | 895 | 0.000 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 1993 | 1455 | 0.000 |
Why?
|